// COMPANY
IntraBio
SECTOR BIOTECHMENTIONS 2LAST SEEN OCTOBER 6, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
m_and_a·PitchBook News·OCTOBER 6, 2026
“IntraBio, which is backed by Oxford Science Enterprises, agreed to be acquired by Tokyo-listed Shionogi in a $2 billion deal.”
Source→02
m_and_a·Axios Pro Rata·OCTOBER 5, 2026
“Shionogi (Tokyo: 4507) agreed to buy IntraBio, an Austin, Texas-based rare disease biotech, for $2b.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.